Exhibit 5.1

| | |
ד"ר ליפא מאיר | אדמית כהן-וינשטוק | ניר מנחם | צח כהן | TZAH COHEN | NIR MENAHEM | ADMIT COHEN-WEINSHTOK | DR. LIPA MEIR |
צוריאל לביא | מאיר אלבוים | קרן בוצר | נוף שדה | NOF SADEH | KEREN BOZER | MEIR ELBAUM | ZURIEL LAVIE |
אלון פומרנץ | טלי לב (II/III) | לילך הוק | תם פישר | TOM FISHER | LILACH HOEK | TALI LEV(II/III) | ALON POMERANC |
ארתור מוהר (I) | סילביה גל-יהב | איתמר ליפנר | עמית ביטון | AMIT BITTON | ITAMAR LIPPNER | SYLVIA GAL-YAHAV | ARTHUR MOHER(I) |
עוזי מור | אסף אילוז | גיא משולם | מאור זילכה | MAOR ZILKA | GUY MESHULAM | ASAF ILUZ | UZI MOR |
גרי קופלוביץ | שי תמר | יוני שטינמץ | נועם שוורץ | NOAM SCHWARTZ | YONI SHTAINMETZ | SHAY TAMAR | GARY COPELOVITZ |
גד אזור | רועי אייז | אלה בן-דור | בן לירז | BEN LIRAZ | ELLA BEN-DOR | ROY AIZ | GAD AZOR |
ארז דר לולו | ד"ר גאי כרמי | טל אסולין-מנחמוב | אביחי אסולין | AVIHAY ASULIN | TAL ASULIN-MENAHEMOV | DR. GUY CARMI | EREZ DAR LULU |
יריב שלום | יעל פלטאו-בילו (I) | יותם וייס | אביב אמר | AVIV AMAR | YOTAM WEISS | YAEL FLATAU-BILU (I) | YARIV SHALOM |
רונן בהרב | נופר טפליץ | רימון דיין | רעות שאולי | REUT SHAULI | RIMON DAYAN | NUPHAR TEPLIZ | RONEN BAHARAV |
ד"ר זיו פרייז (II) | יוסי מנדלבאום | תום ניסני | מורן צויבל | MORAN ZWIEBEL | TOM NISSANI | YOSSI MANDELBAUM | DR. ZIV M. PREIS (II) |
מיכל שורץ | שמרית כרמי-נעמת | ארז גולן (נעים) | תם להב | TOM LAHAV | EREZ GOLAN (NAIM) | SHIMRIT CARMY NAAMAT | MICHAL SCHWARTZ |
שבתאי מיכאלי | עומר מאירי | ישי לבנון | עדי קמחי | ADI KIMHI | ISHAY LEVANON | OMER MEIRI | SHABTAI MICHAELI |
איתן שמואלי | קרנית אקריש | שחף רוט-קליין | | | SHAHAF ROTH-KLEIN | KARNIT AKRISH | EITAN SHMUELI |
אמיר זולטי | יערה פרוינד-אברהם | עידו זבורוף | | | IDO ZABOROF | YAARA FRUEND-AVRAHAM | AMIR ZOLTY |
ארז תיק | גרגורי אירגו | עמית זומר-פדידה | | | AMIT ZOMER-FADIDA | GREGORY IRGO | EREZ TIK |
שירלי יפרח-אזור | יצחק אנידגר | ניר דפני | | | NIR DAFNI | ISAAC ANIDJAR | SHIRLEY IFRACH-AZOR |
ד"ר ציפי איסר איציק | דור אבינרי | שקד ניסן-כהן | | | SHAKED NISSAN-COHEN | DOR AVINERY | DR. TZIPI ISER ITSIQ |
גלי אופינסקי | איילת רם | סיגל ונצובסקי | | | SIGAL VANTSOVSKY | AYELET RAM | GALI OPINSKY |
דוד וינשטיין | ליהי אלימלך | טל מורג | איל חיאט | EYAL KHAYAT | TAL MORAG | LIHI ELIMELECH | DAVID WEINSTEIN |
דנית רימון | רעות בייץ | ירדן הדר | ד"ר יהודה בן מאיר (IV) | DR. YEHUDA BEN-MEIR (IV) | YARDEN HADAR | REUT BEITZ | DANIT RIMON |
ד"ר יריב אילן | יאן פלדמן | שיר דיגמי-טל | ד"ר אירית מבורך (IV) | DR. IRIT MEVORACH (IV) | SHIR DIGMI-TAL | YAN FELDMAN | DR. YARIV ILAN |
| | | | | | | |
2 WEIZMANN ST. TEL AVIV 6423902 ISRAEL, BET AMOT HASHKAOT, FAX:+ 972-3-6070666 :פקס PHONE: +972-3-6070600 :ויצמן 2 ת"א 6423902, בית אמות השקעות, טלפון
April 6, 2020
To:
Safe-T Group Ltd.
8 Abba Eban Ave.
Herzliya, 4672526
Israel
Re: Prospectus Supplement Pursuant to Rule 424(b)(5)
Ladies and Gentlemen,
We have acted as Israeli counsel to Safe-T Group Ltd., a company organized under the laws of the State of Israel (the “Company”), in connection with the issuance and sale by the Company (the “Offering”) of 450,000 American Depositary Shares (the “Offered ADSs”), each representing forty (40) ordinary shares, no par value per share, of the Company (the “Ordinary Shares”). This opinion letter is rendered pursuant to Item 9 of Form F-3 promulgated by the United States Securities and Exchange Commission (the “SEC”) and Items 601(b)(5) and (b)(23) of the SEC’s Regulation S-K promulgated under the United States Securities Act of 1933, as amended (the “Securities Act”).
In connection with this opinion, we have examined the originals, or photocopies or copies, certified or otherwise identified to our satisfaction, of (i) the registration statement on Form F-3 (Registration Statement No. 333-235367) (the “Registration Statement”) filed by the Company with the SEC and as to which this opinion is filed as an exhibit and the prospectus supplement dated April 2, 2020 filed by the Company with the SEC in connection with the registration of certain securities pursuant to Rule 424(b)(5) (the “Prospectus Supplement”), (ii) a copy of the articles of association of the Company as currently in effect (the “Articles”); (iii) resolutions of the board of directors (the “Board”) of the Company which have heretofore been approved and which relate to the Registration Statement, the Prospectus Supplement and the actions to be taken in connection with the Offering; and (iv) such other corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public officials and of officers and representatives of the Company, as we have deemed relevant and necessary as a basis for the opinions hereafter set forth.
In such examination, we have assumed: (i) the authenticity of original documents and the genuineness of all signatures; (ii) the conformity to the originals of all documents submitted to us as copies; (iii) the truth, accuracy and completeness of the information, representations and warranties contained in the corporate records, documents, certificates and instruments we have reviewed; (iv) the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof; and (v) the legal capacity of all natural persons. As to any facts material to such opinion, to the extent that we did not independently establish relevant facts, we have relied on certificates of public officials and certificates of officers or other representatives of the Company.
EMAIL: LAW@LIPAMEIR.CO.IL | WWW.LIPAMEIR.CO.IL |
(I) נוטריון (II) רשיון עו"ד בניו יורק (III) רשיון עו"ד באנגליה (IV) יועץ | (I) NOTARY (II) ADMITTED IN NY (III) ADMITTED IN ENGLAND (IV) OF COUNSEL |

On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Ordinary Shares underlying the Offered ADSs have been duly authorized by the Company, and, upon payment to the Company of the consideration per Offered ADS in such amount and form as described in the Prospectus Supplement, and when issued and sold in the Offering as described in the Prospectus Supplement, will be validly issued, fully paid and non-assessable.
We are members of the Israel Bar and we express no opinion as to any matter relating to the laws of any jurisdiction other than the laws of the State of Israel and have not, for the purpose of giving this opinion, made any investigation of the laws of any other jurisdiction than the State of Israel. This opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated.
We hereby consent to the filing of this opinion as an exhibit to the Report of Foreign Private Issuer on Form 6-K of the Company being filed on the date hereof and to the reference to our firm in the Prospectus Supplement. In giving such consent, we do not believe that we are “experts” within the meaning of such term as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission issued thereunder with respect to any part of the Registration Statement, including this opinion as an exhibit or otherwise.
| Sincerely yours, |
| |
| /s/ Lipa Meir & Co |
WWW.LIPAMEIR.CO.IL | EMAIL: LAW@LIPAMEIR.CO.IL |
- 2 -